As part of Drug Safety Center’s (DSC) commitment to ensuring transparency and inclusiveness in its regulatory processes, DSC announces the launch of a public consultation on the document titled “Guideline On Registration of Medicines According to Verification and Abridged”, available through e-Health Portal. This consultation aims to invite feedback and comments from the public and relevant stakeholders, with the objective of enhancing the clarity, completeness and overall effectiveness of the guideline, while ensuring alignment with best regulatory practices.
-
To collect opinions and feedback from stakeholders.
-
To ensure the comprehensiveness of the guideline.
-
To enhance transparency and accountability in policy development.
-
To strengthen trust between the regulatory authority and the public.
-
To ensure alignment with international best practices
Drug Safety Center invites all citizens, residents, and individuals interested in the health sector to submit their feedback and suggestions regarding the public consultation, during the period from 5 May 2026 to 5 June 2026.
Link for Submitting Feedback and Comments Click Here